Inhibition of TGFβ signaling in cancer therapy
- 27 December 2005
- journal article
- review article
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 16 (1) , 30-37
- https://doi.org/10.1016/j.gde.2005.12.009
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Activated type I TGFβ receptor kinase enhances the survival of mammary epithelial cells and accelerates tumor progressionOncogene, 2005
- Effect of Conditional Knockout of the Type II TGF-β Receptor Gene in Mammary Epithelia on Mammary Gland Development and Polyomavirus Middle T Antigen Induced Tumor Formation and MetastasisCancer Research, 2005
- Conditional Overexpression of Active Transforming Growth Factor β1 In vivo Accelerates Metastases of Transgenic Mammary TumorsCancer Research, 2004
- Smad-Binding Defective Mutant of Transforming Growth Factor β Type I Receptor Enhances Tumorigenesis but Suppresses Metastasis of Breast Cancer Cell LinesCancer Research, 2004
- Increased Malignancy of Neu-Induced Mammary Tumors Overexpressing Active Transforming Growth Factor β1Molecular and Cellular Biology, 2003
- Cytostatic and apoptotic actions of TGF-β in homeostasis and cancerNature Reviews Cancer, 2003
- Transforming growth factor β signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasisProceedings of the National Academy of Sciences, 2003
- Targeting the TGFβ signaling network in human neoplasiaCancer Cell, 2003
- Metastasis is driven by sequential elevation of H-ras and Smad2 levelsNature Cell Biology, 2002
- Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction.Proceedings of the National Academy of Sciences, 1980